Pharmaceutical research is inherently risky and canceled or failed tasks are a normal A part of any drug advancement system. Businesses initiate drug initiatives realizing that Many of them will never yield a marketable drug. 5 In the 2017 review of competition and research and advancement (R&D), The federal government Accountability Office env